Abattis: Northern Vine Labs Expands Its Sales Team (PR)

5 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / May 10, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis“) is pleased to announce the addition of Siobhan McCarthy as Sales & Marketing Manager for the Company’s subsidiary Northern Vine Canada Inc. (“Northern Vine“). Ms. McCarthy brings more than 20 years of direct sales and marketing experience to […]

Abattis Announces the Official Launch of Northern Vine Laboratory (PR)

6 Responses Abattis News | Health Canada | Northern Vine | Raybot

Vancouver, British Columbia / Newsfile Corp / May 3, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce that its subsidiary, Northern Vine Canada Inc. (“Northern Vine“), has officially launched its flagship laboratory, having completed its first successful test analysis. “I am very pleased to announce this significant […]

Abattis Signs Exclusive Distribution Agreement for Proprietary Extraction Technology (PR)

16 Responses Abattis News | Health Canada | Northern Vine | Raybot

VANCOUVER, BC / ACCESSWIRE / April 26, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis“) is pleased to announce that it has signed an exclusive distribution agreement, effective April 20, 2017 (the “Agreement“), with Suzhou Raybot Material Tech Corp. (“Raybot“). The Agreement allows Abattis to use Raybot’s proprietary extraction technology and to exclusively […]

Abattis Bioceuticals Announces New CEO

5 Responses Abattis News | Management | Northern Vine

VANCOUVER, BC / ACCESSWIRE / April 10, 2017 Abattis Bioceuticals Corp. (CSE:ATT) (ATTBF) (the “Company” or “Abattis”) is pleased to announce the appointment of Robert Abenante as President and Chief Executive Officer of the Company. Mr. Abenante is a seasoned executive with extensive public company experience. Mr. Abenante is a Chartered Professional Accountant (CPA, CA) […]

Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC (PR)

3 Responses Abattis News | Marijuana Investment | Northern Vine

VANCOUVER, BC / ACCESSWIRE / April 6, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce it has officially been added to The Marijuana Index, within the Biotechnology sector. The North American Marijuana Index tracks the leading public cannabis companies operating in the United States and Canada and gives investors […]

Canada’s Plans for Near-term Legalization Puts Testing into Focus (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Apr 4, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing the planned legalization of cannabis in Canada, the growing and urgent need for testing in both the existing and upcoming legal cannabis markets, and Abattis […]

Abattis: Legislation to Legalize Marijuana in Canada is Being Announced Next Month (PR)

0 Responses Abattis News | Health Canada | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 27, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), and its subsidiary, Northern Vine Labs, is anticipating the Liberal government’s upcoming announcement, next month (the week of April 10th), on legislation that will legalize recreational marijuana use across Canada by July 1, 2018. As reported by the […]

Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine (PR)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 20, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce that Dr. David Galvez, PhD, will be joining the team to lead Northern Vine’s Science Advisory efforts. Dr. Galvez received his doctorate in Plant Physiology at the University of Alberta and is a seasoned […]

Abattis Team Positions for Next Stage of Growth (PR)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 13, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce the addition of Jaclyn Thomson, PhD, to our senior management team at Northern Vine Labs, and the appointment of Rene David to the Abattis Board of Directors. As the construction and buildout of Northern […]

Abattis Completes Audit and Prepares to Launch Northern Vine Labs (PR)

0 Responses Abattis News | Health Canada | Northern Vine

VANCOUVER, BC / ACCESSWIRE / February 24, 2017 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (“ATT” or the “Company”) is pleased to announce the completion of their annual audit. The delay in filing was due to an eventful year with new programs coming online and an aggressive strategy to cut non-core assets resulting in prolonged consolidations and […]

Abattis Bioceuticals Corp. Announces Postponement of its Annual General Meeting (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / February 14, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company”) is announcing today that it will be seeking to adjourn its upcoming annual general meeting of shareholders, originally scheduled to be held on Friday, February 17, 2017, at 10:00 a.m. (Vancouver time) (the “Meeting”), to a to-be-announced date. The Company […]

Abattis Explores Diversifying with a Strategic Acquisition (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Jan 19, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals Corp. ( OTC PINK : ATTBF ) ( CNSX : ATT ), a specialty agricultural technology firm focused on the legal cannabis industry. […]

Abattis Announces an Independent Valuation on Green Nature Health Care Products (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / January 16, 2017 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (the “Company” or “Abattis”) provides an update to its shareholders. Abattis Bioceuticals Corp. has begun an independent valuation on Green Nature Health Care Products Inc. after the company posted strong performance within their existing and upcoming product catalogue in both Q3 and […]

Abattis Bioceuticals (ATTBF) Northern Vine Labs and the New Canadian Rules (CFN Media)

0 Responses Abattis News | Health Canada | Northern Vine

SEATTLE, WA / Marketwired / Jan 5, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Abattis Bioceuticals Corp.’s ( OTCQB : ATTBF ) ( CSE : ATT ) Northern Vine Labs subsidiary and the effect newly proposed rules in Canada […]

Abattis Provides Corporate Update (PR: 12/16/16)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / December 16, 2016 Abattis Bioceuticals Corp. (ATTBF) (CNSX:ATT) (the “Company” or “Abattis”) provides an update to its shareholder. CEO Rene David provides an update to shareholders after reviewing the latest report from the Canadian Cannabis Task Force on Legalization and Regulation. “After having a chance to review the report, we are even […]

Abattis (ATTBF) Targets Emerging Markets with Nutraceutical Business (CFN Media)

0 Responses Abattis News

SEATTLE, WA / Marketwired / Nov 28, 2016 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Abattis Bioceuticals Corp.’s ( OTCQB : ATTBF ) ( CSE : ATT ) recent expansion of distribution lines in Asia and how those efforts complement […]

Abattis Announces the Appointment of Dr. Shuang Xie as a Director and Provides Progress Report on Initiatives in China (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / November 14, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce the appointment of Dr. Shuang Xie to the Board of Directors. Dr. Xie recently joined Abattis as the Chief Technology Advisor and continues in that capacity. Abattis is also pleased provide an update on […]

Abattis Announces Renewal of Health Canada Licence (PR)

0 Responses Abattis News | Health Canada

VANCOUVER, BC / ACCESSWIRE / November 7, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), announces the renewal of the Health Canada Licence for the Northern Vine Canada Inc. testing lab. Health Canada has confirmed the renewal of the Langley, BC facility’s controlled substances testing licence. The Company has fulfilled Health Canada’s rigorous […]

Abattis Announces the Appointment of New Independent Director (PR)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / November 2, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), announces the appointment of Dr. William Panenka to the Board of Directors. Dr. Panenka received his M.D. and M.Sc. from the University of Calgary in Canada. His M.Sc was basic science-focused utilizing Western Blotting, PCR, in-situ hybridization and […]

Abattis’ Federally Licensed Lab and the Crucial Role It Plays (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Nov 2, 2016 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing Abattis Bioceuticals ( OTCQB : ATTBF ) ( CSE : ATT ). The company recently announced the receipt of a Controlled Substance License from Health […]

Abattis Executes Memorandum of Agreement to Acquire 100% of Experion Biotechnologies Inc. (PR)

0 Responses Abattis News | Experion

VANCOUVER, BC / ACCESSWIRE / October 24, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), announces that Abattis and Northern Vine have entered into a Binding Memorandum of Agreement with Experion Biotechnologies to acquire up to 100% of Experion Biotechnologies Inc. Abattis Bioceuticals Corp., and its subsidiary Northern Vine Canada Inc., expect to […]

Abattis (ATTBF): A Leader in Canada’s Cannabis Testing Industry (CFN Media)

0 Responses Abattis News | Health Canada

SEATTLE, WA / Marketwired / Oct 18, 2016 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Canada’s new cannabis testing regulations and why Abattis Bioceuticals’ ( OTCQB : ATTBF ) Northern Vine Labs is well positioned in this burgeoning market. In […]

Abattis Bioceuticals Corp: Experion Biotechnologies Prepares for Construction (PR)

0 Responses Abattis News | Experion | Northern Vine

VANCOUVER, BC / ACCESSWIRE / October 17, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), announces commencement of construction for the Experion secure, production facility. Experion Biotechnologies Inc. is pleased to announce that it has begun the construction process and prepares to break ground for the six-month build-out for its 8,000 square foot, […]

Abattis Signs MOU with Global Damon Pharma of South Korea (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / October 5, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce that it has entered into a Memorandum of Understanding with Global Damon Pharma (“GDP”) of South Korea, to distribute and sell Abattis’ proprietary PhytoNOS™ and Sassy™ Tonics in modified formulations. GDP will engage in […]

Update: New Science Advisor and Comptroller Appointment to Abattis (PR)

0 Responses Abattis News

VANCOUVER, BC / ACCESSWIRE / September 27, 2016 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce the appointment of Dr. Shuang Xie as its newest Science and Technology Advisor. Dr. Xie graduated from Zhejiang University in 1987 and Queen’s University in 1993. Dr. Xie has been widely published and holds […]